109 related articles for article (PubMed ID: 1534831)
1. Changes in left ventricular dimensions and systolic function in 100 mildly hypertensive men during one year's treatment with atenolol vs. hydrochlorothiazide and amiloride (Moduretic): a double-blind, randomized study.
Otterstad JE; Froeland G; Wasenius Soeyland AK; Knutsen KM; Ekeli T
J Intern Med; 1992 May; 231(5):493-501. PubMed ID: 1534831
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular end-diastolic dimensions measured at the P wave and Q wave during a randomized, double-blind one-year follow-up study comparing the effect of atenolol vs. hydrochlorothiazide + amiloride on blood pressure in men with mild to moderate hypertension.
Otterstad JE; Froeland G; Erikssen J
Scand J Clin Lab Invest; 1993 Apr; 53(2):155-62. PubMed ID: 8469914
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
[TBL] [Abstract][Full Text] [Related]
4. Lipid profile in 100 men with moderate hypertension treated for 1 year with atenolol or hydrochlorothiazide plus amiloride: a double-blind, randomized study.
Otterstad JE; Froeland G; Soeyland AK; Illingworth JM
Scand J Clin Lab Invest; 1992 Apr; 52(2):83-93. PubMed ID: 1589701
[TBL] [Abstract][Full Text] [Related]
5. Atenolol vs. amiloride-hydrochlorothiazide in the treatment of mild to moderate hypertension: a double-blind, crossover, placebo-controlled study.
Lischner M; Lang R; Jutrin I; Ravid M
Drug Intell Clin Pharm; 1987 Jan; 21(1 Pt 1):43-6. PubMed ID: 3545737
[TBL] [Abstract][Full Text] [Related]
6. Are there differences in the blood-pressure-lowering effect of atenolol vs. hydrochlorothiazide + amiloride (Moduretic) when assessed by standard clinic recordings vs. 24-h ambulatory monitoring?
Otterstad JE; Froeland G; Michelsen S; Ekeli T
J Intern Med; 1992 Feb; 231(2):143-4. PubMed ID: 1541937
[No Abstract] [Full Text] [Related]
7. Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA).
Agabiti-Rosei E; Trimarco B; Muiesan ML; Reid J; Salvetti A; Tang R; Hennig M; Baurecht H; Parati G; Mancia G; Zanchetti A;
J Hypertens; 2005 May; 23(5):1091-8. PubMed ID: 15834297
[TBL] [Abstract][Full Text] [Related]
8. Hypertension in the elderly: a study of a combination of atenolol, hydrochlorothiazide and amiloride hydrochloride.
Duckett GK; Cheadle B
Br J Clin Pract; 1990 Sep; 44(9):354-8. PubMed ID: 2223528
[TBL] [Abstract][Full Text] [Related]
9. Effects of hydrochlorothiazide combined with amiloride in atenolol-resistant hypertensive patients.
Corea L; Bentivoglio M; Verdecchia P
Int J Clin Pharmacol Res; 1983; 3(5):367-70. PubMed ID: 6678830
[TBL] [Abstract][Full Text] [Related]
10. Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy.
Dahlof B; Zanchetti A; Diez J; Nicholls MG; Yu CM; Barrios V; Aurup P; Smith RD; Johansson M;
J Hypertens; 2002 Sep; 20(9):1855-64. PubMed ID: 12195129
[TBL] [Abstract][Full Text] [Related]
11. Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial.
Damian DJ; McNamee R; Carr M
BMC Cardiovasc Disord; 2016 Oct; 16(1):188. PubMed ID: 27716064
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic findings and response rates to beta-blocker--and diuretic monotherapy in mild and moderate hypertension. A one year randomized, double blind study in 100 men.
Otterstad JE; Erikssen J; Froeland G; Soeyland AK; Saltvedt E
Blood Press; 1992 Dec; 1(4):212-8. PubMed ID: 1345218
[TBL] [Abstract][Full Text] [Related]
13. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
Kjeldsen SE; Dahlöf B; Devereux RB; Julius S; Aurup P; Edelman J; Beevers G; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Snapinn S; Wedel H;
JAMA; 2002 Sep; 288(12):1491-8. PubMed ID: 12243636
[TBL] [Abstract][Full Text] [Related]
14. Indapamide reduces hypertensive left ventricular hypertrophy: an international multicenter study.
Senior R; Imbs JL; Bory M; Amabile G; Denis B; Zannad F; De Luca N; Marchegiano R; Lahiri A; Raftery EB
J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S106-10. PubMed ID: 7508055
[TBL] [Abstract][Full Text] [Related]
15. Absence of detectable regression of human hypertensive left ventricular hypertrophy following drug treatment for 1 year.
Laufer E; Reid C; Qi XL; Jennings GL
Clin Exp Pharmacol Physiol; 1998; 25(3-4):208-15. PubMed ID: 9590570
[TBL] [Abstract][Full Text] [Related]
16. The effects of antihypertensive therapy on left ventricular mass in elderly patients.
Schulman SP; Weiss JL; Becker LC; Gottlieb SO; Woodruff KM; Weisfeldt ML; Gerstenblith G
N Engl J Med; 1990 May; 322(19):1350-6. PubMed ID: 2139175
[TBL] [Abstract][Full Text] [Related]
17. ACE inhibitor ramipril is more effective than the beta-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) study on behalf of the RACE study group.
Agabiti-Rosei E; Ambrosioni E; Dal Palù C; Muiesan ML; Zanchetti A
J Hypertens; 1995 Nov; 13(11):1325-34. PubMed ID: 8984131
[TBL] [Abstract][Full Text] [Related]
18. [Regression of left heart hypertrophy in hypertensive patients as a result of antihypertensive therapy].
Franz IW; Tönnesmann U; Behr U; Ketelhut R
Z Kardiol; 1989; 78 Suppl 5():43-8. PubMed ID: 2561036
[TBL] [Abstract][Full Text] [Related]
19. Regression of left ventricular hypertrophy during combined atenolol and nifedipine treatment.
Franz IW; Tönnesmann U; Behr U; Ketelhut R
Drugs; 1988; 35 Suppl 4():39-43. PubMed ID: 2967752
[TBL] [Abstract][Full Text] [Related]
20. Enalapril, atenolol, and hydrochlorothiazide in mild to moderate hypertension. A comparative multicentre study in general practice in Norway.
Helgeland A; Strømmen R; Hagelund CH; Tretli S
Lancet; 1986 Apr; 1(8486):872-5. PubMed ID: 2870352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
